Pharmaceutical Executive
Episode 55: Developing a Maternal RSV Vaccine
Apr 30, 2020 · 17 min · 17.2 MB
0:00-17:53
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
Kathrin Jansen, Senior Vice President and Head of Vaccine Research and Development at Pfizer, talks about the challenges of creating a new maternal vaccine for respiratory syncytial virus, also known as RSV, currently being administered to pregnant women in trials, in the hopes of protecting their infants.
No links were found in this episode’s notes.